Aug 4, 2023 · Tambocor: side effects, dosage, interactions, FAQs, reviews. Used for: atrial fibrillation, atrial flutter, paroxysmal supraventricular tachycardia, supraventricular tachycardia, and more.

Oct 8, 2024 · Flecainide is commonly used to help prevent certain types of fast, irregular heartbeats, like paroxysmal supraventricular tachycardia (PSVT) and paroxysmal atrial fibrillation/flutter (PAF), when...

Mar 25, 2021 · Tambocor is an antiarrhythmic prescribed in certain situations to prevent serious heart rhythm disorders including irregular heartbeat (such as persistent ventricular tachycardia and paroxysmal supraventricular tachycardia). Tambocor is also used to prevent certain types of irregular heartbeat from returning (such as atrial fibrillation).

Medscape - Indication-specific dosing for Tambocor (flecainide), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost...

Mar 25, 2025 · Tambocor package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Jun 23, 2022 · Flecainide is a prescription antiarrhythmic medication. It treats a life-threatening irregular or abnormal heartbeat. The brand name is Tambocor®.

Mar 12, 2025 · Detailed dosage guidelines and administration information for Tambocor (flecainide acetate). Includes dose adjustments, warnings and precautions.

Tambocor (flecainide) is used to prevent or treat certain types of life-threatening irregular heartbeats (arrhythmias) such as paroxysmal supraventricular tachycardia (PSVT) and paroxysmal atrial fibrillation/flutter (PAF).

Jan 7, 2025 · tambocor is a class Ic antiarrhythmic agent used to manage atrial fibrillation and paroxysmal supraventricular tachycardias (PSVT). In New Zealand and America, flecainide is indicated to prevent supraventricular arrhythmias and ventricular arrhythmias.

Flecainide is a prescription medication used to treat paroxysmal supraventricular tachycardias (PSVT), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and other supraventricular tachycardias of unspecified mechanism associated with disabling symptoms, paroxysmal atrial fibrillation / flutter (PAF) a...